Provided by Tiger Trade Technology Pte. Ltd.

Biogen

220.77
+2.651.21%
Post-market: 220.770.00000.00%16:20 EDT
Volume:495.31K
Turnover:109.43M
Market Cap:32.59B
PE:39.21
High:222.85
Open:218.93
Low:218.00
Close:218.12
52wk High:222.85
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:0.66
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.73
PE(LYR):25.12

Loading ...

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Kailera Therapeutics Names Nur Nicholson Chief Technology Officer

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors?

Simply Wall St.
·
Aug 09

Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab

TIPRANKS
·
Aug 08

Biogen completes acquisition of RayThera

TIPRANKS
·
Aug 07

Biogen Completes Acquisition of RayThera

Reuters
·
Aug 07

Biogen Completes Acquisition of Raythera Inc.

THOMSON REUTERS
·
Aug 07

Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story

TIPRANKS
·
Aug 07

Biogen Director Lloyd Minor Disposes of 1,186 Common Shares Worth $240,351.94

Reuters
·
Aug 06

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Biogen price target raised to $241 from $221 at Mizuho

TIPRANKS
·
Aug 04

From Products to Innovation: Three Emerging Sectors Anchor China's Economic Growth in 2025

Deep News
·
Aug 04

Stoke Therapeutics Q2 Revenue Falls 33% on Lower Collaboration, Licensing Income

Reuters
·
Aug 04

Biogen is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 04

Mizuho Securities Keeps Their Buy Rating on Biogen (BIIB)

TIPRANKS
·
Aug 03

Biogen : Citigroup Raises Target Price to $215 from $200

THOMSON REUTERS
·
Aug 03

Stifel Nicolaus Remains a Buy on Biogen (BIIB)

TIPRANKS
·
Aug 03

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01